RECRUITING

Improving Health Literacy in African-American Prostate Cancer Patients

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Investigators propose an observational interview study to explore how patients understand treatment conversations with their physicians within the framework of health literacy. The study team will test whether patients' understanding of treatment options and side effects can be improved when patients receive a low literacy educational supplement after meeting with their urologist. Investigators will interview a group of newly diagnosed, early stage, African American prostate cancer patients.

Official Title

Improving Health Literacy in African-American Prostate Cancer Patients

Quick Facts

Study Start:2016-07-21
Study Completion:2027-03-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03322891

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:25 Years to 100 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients who have undergone pathology review of their prostate biopsy at Emory University, Grady Memorial Hospital, Saint Joseph's Hospital, and Atlanta VA Medical Center with AJCC clinical stage T1-T2 prostate cancer by physical exam
  1. * RN or MD degree
  2. * History of head injury or dementia
  3. * History of cognitive impairment
  4. * Unable to undergo the informed consent process and the study interview in English per the judgment of the primary urologist or urological provider

Contacts and Locations

Study Contact

Viraj Master, MD
CONTACT
404-778-4898
vmaster@emory.edu

Principal Investigator

Kerry Kilbridge, MD
PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute

Study Locations (Sites)

Atlanta VA Medical Center
Atlanta, Georgia, 30033
United States
Grady Memorial Hospital
Atlanta, Georgia, 30303
United States
Emory University
Atlanta, Georgia, 30322
United States
Emory Saint Joseph's Hospital
Atlanta, Georgia, 30342
United States

Collaborators and Investigators

Sponsor: Emory University

  • Kerry Kilbridge, MD, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2016-07-21
Study Completion Date2027-03-31

Study Record Updates

Study Start Date2016-07-21
Study Completion Date2027-03-31

Terms related to this study

Keywords Provided by Researchers

  • Urology

Additional Relevant MeSH Terms

  • Prostate Cancer